Lonza Group AG
SIX: LONN.SW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Swiss Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Wolfgang Wienand
- Employees
- 17,995
- Headquarters
- Basel, Switzerland
- IPO year
- 1999
- Market cap
- CHF 33.7B
- Website
- https://www.lonza.com
Loading LONN…
Loading profile data…Frequently asked questions about LONN
What does Lonza Group AG (LONN.SW) do?
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmac...
Where does LONN.SW trade?
Lonza Group AG (LONN.SW) trades on the Swiss Exchange.
What sector is LONN.SW in?
Lonza Group AG (LONN.SW) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Lonza Group AG?
Wolfgang Wienand is the chief executive officer of Lonza Group AG (LONN.SW).
Where is Lonza Group AG headquartered?
Lonza Group AG is headquartered in Switzerland.
Does LONN.SW pay a dividend?
Yes — Lonza Group AG (LONN.SW) paid a trailing twelve-month dividend of CHF 4.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did LONN.SW go public?
Lonza Group AG (LONN.SW) completed its initial public offering in 1999.